Novo Nordisk’s Fiasp gains FDA approval for fast-acting insulin, enhancing diabetes management in US

Novo Nordisk, a leading Danish pharmaceutical company, has secured a significant regulatory milestone with the US FDA approval of its innovative fast-acting mealtime insulin aspart ... Read More